Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Skin Biopsy Market, by Region, 2019-2029 (USD Billion)
1.2.2. Skin Biopsy Market, by Type, 2019-2029 (USD Billion)
1.2.3. Skin Biopsy Market, by Indication, 2019-2029 (USD Billion)
1.2.4. Skin Biopsy Market, by End-User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Skin Biopsy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Skin Biopsy Market Dynamics
3.1. Skin Biopsy Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Growing prevalence of skin cancer
3.1.1.2. Rise in incidences of skin disorders
3.1.2. Market Challenges
3.1.2.1. High cost of skin biopsy procedures
3.1.2.2. Presence of new alternatives to skin biopsies
3.1.3. Market Opportunities
3.1.3.1. Growing adoption of minimally invasive procedures
Chapter 4. Global Skin Biopsy Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Skin Biopsy Market, by Type
6.1. Market Snapshot
6.2. Global Skin Biopsy Market by Type, Performance – Potential Analysis
6.3. Global Skin Biopsy Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
6.4. Skin Biopsy Market, Sub Segment Analysis
6.4.1. Shave Biopsy
6.4.2. Punch Biopsy
6.4.3. Excisional Biopsy
Chapter 7. Global Skin Biopsy Market, by Indication
7.1. Market Snapshot
7.2. Global Skin Biopsy Market by Indication, Performance – Potential Analysis
7.3. Global Skin Biopsy Market Estimates & Forecasts by Indication 2019-2029 (USD Billion)
7.4. Skin Biopsy Market, Sub Segment Analysis
7.4.1. Skin cancer
7.4.2. Actinic keratosis
7.4.3. Dermatitis
7.4.4. Others
Chapter 8. Global Skin Biopsy Market, by End-User
8.1. Market Snapshot
8.2. Global Skin Biopsy Market by End-User, Performance – Potential Analysis
8.3. Global Skin Biopsy Market Estimates & Forecasts by End-User 2019-2029 (USD Billion)
8.4. Skin Biopsy Market, Sub Segment Analysis
8.4.1. Hospital and Clinics
8.4.2. Diagnostic Laboratories
8.4.3. Other
Chapter 9. Global Skin Biopsy Market, Regional Analysis
9.1. Skin Biopsy Market, Regional Market Snapshot
9.2. North America Skin Biopsy Market
9.2.1. U.S. Skin Biopsy Market
9.2.1.1. Type breakdown estimates & forecasts, 2019-2029
9.2.1.2. Indication breakdown estimates & forecasts, 2019-2029
9.2.1.3. End-User breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Skin Biopsy Market
9.3. Europe Skin Biopsy Market Snapshot
9.3.1. U.K. Skin Biopsy Market
9.3.2. Germany Skin Biopsy Market
9.3.3. France Skin Biopsy Market
9.3.4. Spain Skin Biopsy Market
9.3.5. Italy Skin Biopsy Market
9.3.6. Rest of Europe Skin Biopsy Market
9.4. Asia-Pacific Skin Biopsy Market Snapshot
9.4.1. China Skin Biopsy Market
9.4.2. India Skin Biopsy Market
9.4.3. Japan Skin Biopsy Market
9.4.4. Australia Skin Biopsy Market
9.4.5. South Korea Skin Biopsy Market
9.4.6. Rest of Asia Pacific Skin Biopsy Market
9.5. Latin America Skin Biopsy Market Snapshot
9.5.1. Brazil Skin Biopsy Market
9.5.2. Mexico Skin Biopsy Market
9.5.3. Rest of Latin America Skin Biopsy Market
9.6. Rest of The World Skin Biopsy Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. AccuTec, Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Cardinal Health Inc.
10.2.3. Innovia Medical
10.2.4. Jai Surgicals Ltd.
10.2.5. Integra LifeSciences
10.2.6. Vernacare
10.2.7. Becton Dickinson and Company
10.2.8. KAI Group
10.2.9. Paramount Surgimed Limited
10.2.10. World Precision Instruments
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/